Dapagliflozin Prevents Cardiac Surgery-Associated AKI
In patients undergoing elective cardiac surgery, four doses of dapagliflozin beginning the day before the operation significantly reduced the incidence of postoperative acute kidney injury during the 7-day recovery period, according to a multicenter placebo-controlled trial published in JAMA. The trial found that dapagliflozin lowered AKI incidence to 28% compared with 52% in the placebo … Read more